Statement in response to latest ATAGI advice regarding COVID-19 vaccines

17 June 2021 - A statement from the Professor Paul Kelly, Australian Government Chief Medical Officer in response to the latest ...

Read more →

COVID-19 vaccine weekly safety report (17 June 2021)

17 June 2021 - Twelve additional cases of blood clots with low blood platelets have been assessed as thrombosis with thrombocytopenia ...

Read more →

Vaxzevria: EMA advises against use in people with history of capillary leak syndrome

11 June 2021 - EMA’s safety committee (PRAC) has concluded that people who have previously had capillary leak syndrome must not ...

Read more →

COVID-19 vaccine weekly safety report (10 June 2021)

10 June 2021 - Seven additional cases of blood clots with low blood platelets have been assessed as thrombosis with ...

Read more →

ATAGI update following weekly COVID-19 meeting – 9 June 2021

10 June 2021 - An update from the Australian Technical Advisory Group on Immunisation following their weekly meeting on 9 June ...

Read more →

Innovative regenerative medicine therapies – patient safety comes first

3 June 2021 - The U.S. FDA continues to facilitate the development and availability of innovative medical products, such as regenerative ...

Read more →

EMA raises awareness of clinical care recommendations to manage suspected thrombosis with thrombocytopenia syndrome

7 June 2021 - EMA’s COVID-19 taskforce (COVID-ETF) is advising health care professionals in the EU to consider recommendations by learned ...

Read more →

COVID-19 vaccine weekly safety report (3 June 2021)

3 June 2021 - Eight additional cases of blood clots with low blood platelets have been assessed as thrombosis with thrombocytopenia ...

Read more →

COVID-19 vaccine weekly safety report (27 May 2021)

27 May 2021 - Nine additional cases of blood clots with low blood platelets have been assessed as thrombosis with thrombocytopenia ...

Read more →

Influencers say they were urged to criticise Pfizer vaccine

26 May 2021 - A disinformation effort to reduce public confidence in COVID-19 vaccines tried to enrol social media commentators in ...

Read more →

ATAGI/THANZ statement provides further guidance for the AstraZeneca vaccine and narrows contra-indication

23 May 2021 - The Australian Technical Advisory Group on Immunisation and the Thrombosis and Haemostasis Society of Australia and New ...

Read more →

Vaxzevria: further advice on blood clots and low blood platelets

21 May 2021 - EMA has provided additional advice on blood clots or low blood platelets occurring after vaccination with Vaxzevria ...

Read more →

COVID-19 vaccine weekly safety report

20 May 2021 - Six additional cases of blood clots with low blood platelets have been assessed as thrombosis with thrombocytopenia ...

Read more →

Statement from Health Canada on Janssen COVID-19 vaccines and Emergent BioSolutions

30 April 2021 - Health Canada continues to ensure the quality and safety of vaccines coming into Canada by working ...

Read more →

COVID-19 vaccine weekly safety report - 28-04-2021

29 April 2021 - The TGA has been closely monitoring suspected adverse events from the use of COVID-19 vaccines since the ...

Read more →